Nisshin Kyorin Pharmaceutical announced on August 24 that it has concluded a cooperative sales agreement with Yakult Honsha for “Sinseron Tablet 8 mg,” a serotonin 5-HT3 receptor antagonist with antiemetic property.
Nisshin Kyorin Pharmaceutical announced on August 24 that it has concluded a cooperative sales agreement with Yakult Honsha for “Sinseron Tablet 8 mg,” a serotonin 5-HT3 receptor antagonist with antiemetic property.
